- Lobbying
- MIKE AND FERGUSON
Lobbying Arrangements Results for 'Mike Ferguson'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Health care legislation; renewable energy legislation; telecommunications legislation; financial services legislation. |
Ferguson Strategies, LLC
|
in-house lobbying | |||
Details Policy issues, including regulatory and payment matters, relating to aneurysmal subarachnoid hemorrhage. |
Edge Therapeutics Inc.
Biotechnology manufacturer. |
Ferguson Strategies, LLC | |||
Details Policy issues relating to corporate tax reform, including international tax rules. |
Prudential Financial Inc.
|
Ferguson Strategies, LLC | |||
Details Workforce Development. Workforce Investment Act, FY 2013 Department of Labor appropriations. |
Get Into Energy Consortium
|
The Ferguson Group, LLC | |||
Details Policy issues relating to competitive bidding for durable medical equipment, including H.R. 1717, the "Medicare DMEPOS Market Pricing Program Act" and H.R.2375, the "Transparency and Accountability... |
US Healthcare Supply, LLC
|
Ferguson Strategies, LLC | |||
Details CMS reimbursement issues relating to durable medical equipment suppliers. |
Care Concepts Louisiana, Inc.
|
Ferguson Strategies LLC | |||
Details Public policy issues that promote renewable energy, including for dual-use applications. |
Lightening Energy
|
Ferguson Strategies LLC | |||
Details H.R. 6, the "21st Century Cures Act," specifically policy issues relating to combination pharmaceutical products. Policy issues relating to corporate tax reform, including international tax rules. |
Aralez Pharmaceuticals US, Inc. (formerly Pozen Inc.)
|
Ferguson Strategies, LLC | |||
Details Defense Department POW/MIA identification issues, specifically relating to Section 1509(f)(2)(d)(2) of the FY 2010 National Defense Authorization Act. |
Bode Technology Group, Inc.
|
Ferguson Strategies LLC | |||
Details H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry. |
Integra LifeSciences Corp.
|
Ferguson Strategies, LLC | |||
Details H.R. 6, the "21st Century Cures Act." Policy issues relating Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically Section 902 relating to the Breakthro... |
Advaxis, Inc.
|
Ferguson Strategies, LLC | |||
Details Legislation to create a national electronic database to track sales of products containing pseudophedrine. |
Merck & Co., Inc.
|
Ferguson Strategies LLC | |||
Details H.R. 6, the "21st Century Cures Act." H.R. 512, the "Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act." S. 145, the "Promise for Antibiotics and Therapeutics for He... |
The Medicines Company
Pharmaceutical manufacturer. |
Ferguson Strategies, LLC | |||
Details Grant funding opportunities for local economic development projects. |
Vance County Tourism Development Authority
|
The Ferguson Group | |||
Details Policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." Policy and implementation issues relating to Public Law No. 112-144, the "Food... |
Genentech, Inc.
Biotechnology research and manufacturer. |
Ferguson Strategies, LLC | |||
Details Policy issues relating to federal healthcare regulatory and reimbursement matters. |
Yamo Pharmaceuticals, LLC
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Insmed Incorporated
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to U.S. trade embargo on Cuba |
Engage Cuba
|
BAKER & HOSTETLER LLP | |||
Details Agriculture Appropriations bill for FY 2014 and 2015. |
North Carolina Association of Electric Cooperatives
|
The Ferguson Group, LLC | |||
Details Policy issues related to international trade. |
Global Automakers
|
BAKER & HOSTETLER LLP | |||
Details Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Prescription Drug User Fee program. Policy and i... |
Eli Lilly and Company
|
Ferguson Strategies, LLC | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Strongbridge Biopharma, PLC
|
BAKER & HOSTETLER LLP | |||
Details Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Me... |
Novartis
|
Ferguson Strategies, LLC | |||
Details H.R. 6, the "21st Century Cures Act." Policy and implementation issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections ... |
Pharmaceutical Research and Manufacturers of America
|
Ferguson Strategies, LLC | |||
Details S. 2012, the "Energy Policy Modernization Act." H.R. 8, the "North American Energy Security and Infrastructure Act." Policy issues relating to corporate tax reform, including international tax rules. |
Public Service Enterprise Group
|
Ferguson Strategies, LLC | |||
Details Policy issues relating to transparency and conflicts of interest in the financial services' proxy advisory industry, and capital markets structure. H.R. 1839, the "Reforming Access for Investments ... |
NASDAQ (formerly NASDAQ OMX Group)
Stock exchange. |
Ferguson Strategies, LLC | |||
Details Policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." Policy and implementation issues relating to Public Law No. 112-144, the "Food... |
Dendreon Corp.
|
Ferguson Strategies, LLC | |||
Details Telecommunications policy, including as it relates to legislative and regulatory initiatives affecting broadband, video and wireless. |
Verizon Services Corp.
|
Ferguson Strategies LLC | |||
Details Base Realignment and Closure (BRAC); sequestration; federal facilities; defense budget and appropriations; defense issues affecting Fairfax County, Virginia. |
The Ferguson Group (on behalf of Fairfax County Virginia)
Legislative research, tracking, monitoring and advocacy services |
Poyner Spruill LLP | |||
Details Base Realignment and Closure (BRAC); sequestration; federal facilities, defense issues including highway expenditures related to servicing military hospitals affecting Fairfax County, Virginia. |
The Ferguson Group (on behalf of Fairfax County, Virginia)
|
WARD AND SMITH, P.A. | |||
Details Appropriations for the Departments of Labor, Health and Human Services for FY 2013. |
NOVANT HEALTH
|
FERGUSON GROUP | |||
Details Health care reform legislation, including safety and data exclusivity issues regarding follow-on biologics. |
HOFFMANN-LA ROCHE INC.
|
Ferguson Strategies LLC | |||
Details Regulatory and public policy issues regarding Tricare reimbursement. |
AKRIMAX PHARMACEUTICALS, LLC
|
Ferguson Strategies LLC | |||
Details Regulatory and public policy issues regarding Tricare reimbursement. |
Triax Pharmaceuticals LLC
|
Ferguson Strategies LLC | |||
Details Policy issues relating to digital currencies. |
Ripple Labs, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement issues relating to pharmaceutical products. |
Depomed Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and payment issues relating to medical technology manufacturers. |
Integra LifeSciences Corp.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Tyme Technologies, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act |
Genentech, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues including regulatory and payment matters relating to aneurysmal and subarachnoid hemorrhage; HR 1648, the Ellie Helton, Lisa Colagrossi, Teresa Anne Lawrence, and Jennifer Sedney Focu... |
Edge Therapeutics, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Advocating for an alternative to the chargemaster for Medicare payment. |
Chargemaster Alternatives for Medicare Payment Alliance (ChAMP)
|
Leavitt Partners, LLC | |||
Details Policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program. |
Gilead Sciences, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Federal regulatory policy issues related to bioidentical hormone replacement therapy. |
Bioidentical Hormone Replacement Therapy Coalition
|
BAKER & HOSTETLER LLP | |||
Details Healthcare policy; Medicare Part B. and essential health benefits requirements of Public Law 111-148, the Affordable Care Act; H.R. 1628, American Health Care Act |
Aeroflow Healthcare
|
BAKER & HOSTETLER LLP | |||
Details Seeking to amend the Physician Fee Schedule (PFS) and the Hospital Outpatient Prospective Payment System (OPPS) to recognize and value the unique contribution of artificial intelligence (AI) to med... |
National Electrical Manufacturers Association
|
Leavitt Partners, LLC | |||
Details Reimbursement issues for biotechnology manufacturers, including Medicare Part B |
Ophthotech Corp.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
UroGen Pharma Ltd.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act Policy issues relat... |
Pentec Health, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement issues related to medical technology, including diagnostics. |
SQI Diagnostics
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to outsourcing facilities as defined under Sec. 503B of Public Law No. 113-54, the Drug Quality and Security Act. |
Outsourcing Facilities Association
|
BAKER & HOSTETLER LLP |